MRK — Merck KGaA Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Merck KGaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,152	17,534	19,687	22,232	20,993
Cost of Revenue
Gross Profit	10,201	10,752	12,362	13,819	12,623
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,032	14,549	15,508	17,758	17,384
Operating Profit	2,120	2,985	4,179	4,474	3,609
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,735	2,630	3,924	4,287	3,484
Provision for Income Taxes
Net Income After Taxes	1,295	1,993	3,065	3,339	2,834
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,320	1,986	3,055	3,325	2,824
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,320	1,987	3,055	3,326	2,824
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.64	4.72	7.36	8.77	7.67
Dividends per Share